MICHAEL POULIN: Open Payments
NPI 1306265723 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 7 payments from 5 companies in 2025. Trend: 2023 $352 · 2024 $346 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| HEARTFLOW, INC. | 2 | $98 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Novo Nordisk Inc | 1 | $16 |
Products named: FFRct, LEQVIO, AMVUTTRA, VERQUVO, Wegovy.
Industry payments across NV — which companies pay providers there.
